151 related articles for article (PubMed ID: 11598617)
21. Cardiovascular health, growth and gonadal function in children and adolescents with congenital adrenal hyperplasia.
Mooij CF; Webb EA; Claahsen van der Grinten HL; Krone N
Arch Dis Child; 2017 Jun; 102(6):578-584. PubMed ID: 27974295
[TBL] [Abstract][Full Text] [Related]
22. [Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: final height in 27 patients with the classical form].
Lemos-Marini SH; Guerra-Júnior G; Morcillo AM; Baptista MT; Silva LO; Maciel-Guerra AT
Arq Bras Endocrinol Metabol; 2005 Dec; 49(6):902-7. PubMed ID: 16544012
[TBL] [Abstract][Full Text] [Related]
23. Early hypertension and prolonged mineralocorticoid therapy discontinuation in a child with salt-wasting 21-hydroxylase deficiency.
Wasniewska M; Valenzise M; Aversa T; Mirabelli S; De Luca F; De Luca FL; Lombardo F
J Endocrinol Invest; 2011 Feb; 34(2):159-61. PubMed ID: 21502797
[No Abstract] [Full Text] [Related]
24. [Treatment of the adrenogenital syndrome in childhood. (Personal experiences and reference to avoidable errors)].
Helwig H
Monatsschr Kinderheilkd (1902); 1966 Apr; 114(4):261-5. PubMed ID: 5985811
[No Abstract] [Full Text] [Related]
25. Gender dichotomy in long term growth trajectories of children with 21-hydroxylase deficiency congenital adrenal hyperplasia.
Patel L; Chandrashekhar SR; Gemmell I; O'Shea E; Jones J; Banerjee I; Amin R; Clayton P
Horm Res Paediatr; 2011; 75(3):206-12. PubMed ID: 20962509
[TBL] [Abstract][Full Text] [Related]
26. Selective effect of mineralocorticoid replacement therapy on renal acid excretion in congenital adrenal hyperplasia.
Simón J; Mendizabal S; Martinez F; Carles C; Zamora I
Acta Paediatr Scand; 1990; 79(6-7):652-7. PubMed ID: 2386057
[TBL] [Abstract][Full Text] [Related]
27. Growth patterns and outcomes in congenital adrenal hyperplasia; effect of chronic treatment regimens.
Rasat R; Espiner EA; Abbott GD
N Z Med J; 1995 Aug; 108(1005):311-4. PubMed ID: 7644165
[TBL] [Abstract][Full Text] [Related]
28. Randomised controlled trial of growth effect of hydrocortisone in congenital adrenal hyperplasia.
Silva IN; Kater CE; Cunha CF; Viana MB
Arch Dis Child; 1997 Sep; 77(3):214-8. PubMed ID: 9370898
[TBL] [Abstract][Full Text] [Related]
29. [Adrenogenital syndrome].
Fujieda K
Nihon Rinsho; 2006 Jun; Suppl 2():643-6. PubMed ID: 16817483
[No Abstract] [Full Text] [Related]
30. The effect of therapy on mature height in congenital adrenal hyperplasia.
Kirkland RT; Keenan BS; Holcombe JH; Kirkland JL; Clayton GW
J Clin Endocrinol Metab; 1978 Dec; 47(6):1320-4. PubMed ID: 263352
[No Abstract] [Full Text] [Related]
31. [Growth and development in congenital adrenogenital syndrome].
Hostomská L; Brachfeldová J; Jozífko M; Komínek J; Lisá L; Nováková M; Sedlácková E; Spicáková V; Veselý K; Votava V
Cesk Pediatr; 1972 Oct; 27(10):479-83. PubMed ID: 5078508
[No Abstract] [Full Text] [Related]
32. Unresolved problems in the treatment of congenital adrenal hyperplasia.
Tanae A; Hibi I
Acta Paediatr Jpn; 1988; 30 Suppl():93-8. PubMed ID: 3146884
[No Abstract] [Full Text] [Related]
33. Editorial--Growth and its disorders.
Menon PS
Indian J Pediatr; 2006 Jan; 73(1):65-6. PubMed ID: 16444064
[No Abstract] [Full Text] [Related]
34. Health problems in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Reisch N; Arlt W; Krone N
Horm Res Paediatr; 2011; 76(2):73-85. PubMed ID: 21597280
[TBL] [Abstract][Full Text] [Related]
35. Adrenal steroidogenesis and congenital adrenal hyperplasia.
Turcu AF; Auchus RJ
Endocrinol Metab Clin North Am; 2015 Jun; 44(2):275-96. PubMed ID: 26038201
[TBL] [Abstract][Full Text] [Related]
36. Patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency can achieve their target height: the Leipzig experience.
Hoepffner W; Kaufhold A; Willgerodt H; Keller E
Horm Res; 2008; 70(1):42-50. PubMed ID: 18493149
[TBL] [Abstract][Full Text] [Related]
37. Osteocalcin in congenital adrenal hyperplasia.
Lisá L; Neradilová M; Tomásová N; Soutorová M; Zimák J
Bone; 1995 Jan; 16(1):57-9. PubMed ID: 7742084
[TBL] [Abstract][Full Text] [Related]
38. Impact of hydrocortisone on adult height in congenital adrenal hyperplasia-the Minnesota cohort.
Sarafoglou K; Addo OY; Turcotte L; Otten N; Wickremasinghe A; Pittock S; Kyllo J; Lteif AN; Himes JH; Miller BS
J Pediatr; 2014 May; 164(5):1141-1146.e1. PubMed ID: 24560184
[TBL] [Abstract][Full Text] [Related]
39. Should we monitor more closely the dosage of 9 alpha-fluorohydrocortisone in salt-losing congenital adrenal hyperplasia?
Lopes LA; Dubuis JM; Vallotton MB; Sizonenko PC
J Pediatr Endocrinol Metab; 1998; 11(6):733-7. PubMed ID: 9829228
[TBL] [Abstract][Full Text] [Related]
40. Impaired systolic and diastolic left ventricular function in children and adolescents with congenital adrenal hyperplasia receiving corticosteroid therapy.
Tuhan H; Demircan T; Altıncık A; Çatlı G; Kızılca Ö; Egeli T; Kır M; Can Ş; Dündar B; Böber E; Abacı A
Cardiol Young; 2019 Mar; 29(3):319-324. PubMed ID: 30675832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
